This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zakar, T. Articles by Olson, D. M. Search for Related Content PubMed PubMed Citation Articles by Zakar, T. Articles by Olson, D. M.

Regulation of prostaglandin endoperoxide H synthase by glucocorticoids and activators of protein kinase C in the human amnion

Since glucocorticoids decrease and protein kinase C (PKC) activators increase amniotic PGE₂ production, the possibility that they regulate the activity of prostaglandin endoperoxide H synthase (PGHS), the rate-limiting enzyme of prostaglandin synthesis from arachidonate, was investigated. Glucocorticoids inhibited the production of PGE₂ from exogenous arachidonate specifically and in a concentration dependent fashion. Furthermore, cortisol decreased PGHS activity and the amount of PGHS protein in amnion microsomes, and reduced the rate of recovery of PGHS after acetylsalicylic acid (ASA) pretreatment. Actinomycin D blocked the inhibition of PGHS recovery by cortisol, but did not suppress the spontaneous recovery of the enzyme, indicating that the glucocorticoid induced a post-transcriptional inhibitor of PGHS synthesis. PKC-activating phorbol esters, such as 12-tetradecanoyl phorbol 13-acetate (TPA) increased the synthesis of PGE₂ from exogenous arachidonate, also in a specific and concentration dependent manner. PGHS recovery after ASA treatment was enhanced by TPA. PGHS activity and protein concentrations were increased by phorbol ester treatment; however, this was apparent only in tissues in which the concentrations of PGHS were initially low. These results show that the synthesis of PGHS is positively and negatively regulated in the human amnion by PKC and glucocorticoids, respectively, and suggest that effectors using these pathways may regulate the enzyme in vivo.

This article has been cited by other articles:

				C. E. Wood Estrogen/Hypothalamus-Pituitary-Adrenal Axis Interactions in the Fetus: the Interplay Between Placenta and Fetal Brain Reproductive Sciences, February 1, 2005; 12(2): 67 - 76. [Abstract] [PDF]

				F. Doualla-Bell and A. E. Koromilas Induction of PG G/H Synthase-2 in Bovine Myometrial Cells by Interferon-{tau} Requires the Activation of the p38 MAPK Pathway Endocrinology, December 1, 2001; 142(12): 5107 - 5115. [Abstract] [Full Text] [PDF]

				E. Karteris, D. Grammatopoulos, H. Randeva, and E. W. Hillhouse Signal Transduction Characteristics of the Corticotropin-Releasing Hormone Receptors in the Feto-Placental Unit J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1989 - 1996. [Abstract] [Full Text]

				J. L. Cook, D. B. Zaragoza, D. H. Sung, and D. M. Olson Expression of Myometrial Activation and Stimulation Genes in a Mouse Model of Preterm Labor: Myometrial Activation, Stimulation, and Preterm Labor Endocrinology, May 1, 2000; 141(5): 1718 - 1728. [Abstract] [Full Text] [PDF]